MWCapital Barcelona appoints Albert Mascarell as new Director of Tech Transfer 

He will lead the national and European expansion of the foundation’s program to identify disruptive technological solutions emerging from universities and research centres and bring them to market. 

23/April/2025

Mobile World Capital Barcelona (MWCapital) has appointed Albert Mascarell as its new Director of Tech Transfer to boost this area, one of the foundation’s key pillars, at both the national and European levels. 

Mascarell will spearhead the expansion of MWCapital’s program to identify disruptive technological solutions from universities and research centres and support their journey to market. 

The new Director of Tech Transfer at MWCapital is a biotechnologist and bioinformatician, and an expert in innovation, tech transfer, and venture building within the biotech, health, and deeptech sectors. For over a decade, he has driven and advised numerous scientific and technological startups, acting as CEO, co-founder, and mentor. 

He was previously CEO of BHV Partners, a health-focused venture builder, where he led the creation and standardisation of acceleration and investment methodologies. Among his most notable achievements is the founding of a personalised medicine startup, acquired by a publicly listed Belgian-Dutch pharmaceutical group, which went on to internationalise in over 30 countries. 

Mascarell also collaborates with institutions such as the European Innovation Council (EIC) and regularly participates as a mentor, trainer, and speaker for organisations including Biocat, EIT Health, SPRI, ACCIÓ, SGS, IESE, and BSM-UPF, among others. 

In this new role, Mascarell faces the challenge of extending the tech transfer programme to more centres across Catalonia, Spain, and Europe. He believes that “helping move technology and science from the lab to the business world is one of Europe’s main strategies to secure technological sovereignty. At the Mobile World Capital Barcelona Foundation, we have a proven, scalable model that enables us to bring deep, science-based technological solutions with social impact to market.” 

A commitment to tech transfer 

Currently, 95% of European patents never make it to market. MWCapital’s tech transfer programme is committed to identifying innovations from universities and research centres and facilitating their transition into industrial solutions that benefit society. 

Since its inception eight years ago, MWCapital’s tech transfer programme has supported over 200 research projects, driven the creation of 22 spin-offs that have generated more than 170 jobs, and currently has a portfolio of 12 companies in sectors such as energy and sustainability, health, and industrial and logistics solutions. Together, these companies are valued at over €100 million.